An Inadequate and Misdirected Health Budget

The Budget allocation for the health sector is not even one-third of the target laid out in the draft National Health Policy.

The Budget allocation for the health sector is not even one-third of the target laid out in the draft National Health Policy.

Pharmacists dispense free medication, provided by the government, to patients at Rajiv Gandhi Government General Hospital in Chennai July 12, 2012. Credit: Reuters/Babu/Files

Pharmacists dispense free medication, provided by the government, to patients at Rajiv Gandhi Government General Hospital in Chennai July 12, 2012. Credit: Reuters/Babu/Files

The draft National Health Policy (NHP) 2015, based on the core principles of equity, universality and affordability, had set three major objectives for the public health sector: expanding preventive, promotive, curative, palliative and rehabilitative services to improve population health status; assuring universal availability of free, comprehensive primary healthcare services; and significantly reducing out-of-pocket expenditure by ensuring affordable secondary and tertiary care services. These booming ambitions, though, were promptly toned down, “taking into account the financial capacity of the country” as it set minimalist fiscal targets for itself: public health expenditure of 2.5% of GDP, 40% of which – i.e. 1% of GDP – would come from the central expenditures.

Inadequate allocations

This year’s central health Budget at 0.29% of GDP – which is marginally better than previous years’ level of 0.26% – is not even one-third of that target. At constant prices, adjusting for inflation (using GDP deflators), this year’s total allocations have increased by 18% over previous years’ expenditures. This appears to be noticeable only because growth of public expenditure on health in the past few years has been marginal. Compared to an expenditure of Rs 26,567 crore in 2013-14 – a year preceding the election of the current government – an allocation of Rs 37,471 crore for 2017-18 (both years’ values at 2011-12 constant prices) represents an annual increase by only 9% (compound annual growth rate or CAGR). Growth of per-capita expenditures for the same period is 7.7% (calculation using UN Population Division estimates).

Source: Union Budget documents

Source: Union Budget documents

Misplaced priorities

The modest increase by 18% (at constant prices) in total allocation is largely concentrated in tertiary and secondary care sectors. More than one-fourth of this increase (at constant prices) is allocated to upgrade district hospitals into new medical colleges under National Health Mission. Another 26% of the increase in total allocation is on the Pradhan Mantri Swasthya Suraksha Yojana, which is for setting up new AIIMS and upgrading medical colleges.

On the other hand, this Budget completely marginalises primary care and public health. Over the past years, the National Rural Health Mission (NRHM) has been badly neglected, with its share in this year’s central health Budget coming down to 43% (Budget estimates) from 53% (actual) in 2015-16. Within the NRHM, there is an increase of allocation by Rs 2,000 crore (constant 2011-12 prices) under ‘health system strengthening’, which largely will go into transforming 1.5 lakh health sub-centres into ‘health and wellness centres’.

This modest increase in health system strengthening is almost matched by a reduced allocation in reproductive and child health (including immunisation), communicable diseases and maintenance of existing infrastructure. This means that existing public health and primary care facilities, particularly the primary health centres (PHCs) and community health centres (CHCs), will further underperform and lag behind the rural population’s health needs due to a shortage of funds. These rearrangements of sub-heads without any overhaul of allocations to build new infrastructure means the shortfall of 33,000 health sub-centres, along with 22% and 32% shortage of PHCs and CHCs, will still persist. On the whole, a marginal increase in this year’s Budget allocation for NRHM by 4.4% (2011-12 constant prices) over last year’s expenditures (revised estimates) is a death knell for the dying rural public healthcare sector.

The NRHM’s urban counterpart, the National Urban Health Mission (NUHM), is yet to start properly. For the period 2012-13 to 2016-17, its average yearly budgetary requirement was estimated to be Rs 3,391 crore per year from central funds; this year’s allocation is only Rs 752 crore.

The insurance conundrum

Strengthening and deepening a subsidised public healthcare system is a much cheaper option to ensure universal access to healthcare, rather than subsidising private providers via insurances. Yet, the poor perhaps had hoped for a modest health protection following last year’s Independence Day promise by the prime minister about Rs 1 lakh insurance coverage for every BPL family under a redesigned RSBY – now the National Health Protection Scheme (NHPS). The finance minister’s Budget speech, though made no mention of this.

This year’s allocation to RSBY/NHPS, though increasing marginally from last year’s expenditures (revised estimates), has declined compared to last year’s budgeted amount by Rs 500 crore (nominal terms). Upscaling the RSBY to NHPS in the proposed manner was estimated to cost Rs 24,000 crore for five years or on average of Rs 4,800 per year. Allocating Rs 4,800 for NHPS alone would have required more than a 12% increase (in nominal terms) in allocation from last year’s expenditures. With an obvious resource crunch (along with reducing fiscal deficit by 0.3% of GDP), like the implementation of NRHM, implementation of  NHPS in the proposed form would have meant even lesser allocation in other sub-sectors of this pretty meagre health Budget which the government could not have afforded in a crucial election year.

Neglect of allied sectors

Outlay on Integrated Child Development Services (ICDS) and other components of child welfare taken together (from here on, termed together as umbrella child welfare or UCW) increased from last year’s expenditures at constant prices. This was primarily due to upscaling the Indira Gandhi Matritva Sahyog Yojana (providing Rs 6,000 to women undergoing an institutional delivery and vaccinating their children) from pilot districts all over the country. This is a welcome and much awaited move (in spite of some of its flaws), though the quantum of provision (Rs 6,000), which was originally laid down in the National Food Security Act in 2013, should have been increased. On the other hand, allocation in core ICDS (anganwadi services) at constant prices barely increased from last year’s expenditures and the overall trend from 2013-14 till this year shows a yearly decline by 5%.

A damning Niti Ayog Report of 2015, based on a rapid survey, showed that around 41% of anganwadis have inadequate space, 71% are not visited by doctors, 31% have no nutritional supplementation for malnourished children and 52% have bad hygienic conditions. Given this abysmal state, setting up of mahila shakti Kendras in 14 lakh anganwadi centres – as highlighted by the finance minister – with a measly allocation of Rs 500 crore (Rs 3,600 per anganwadi for a year) is a mere eye wash. ICDS anganwadi service today requires a comprehensive overhaul with substantial increase in outlay.

In comparison, food subsidy and MNREGA appear to be in a slightly better position, with a minor annual increase in expenditure (at constant prices) between 2013-14 and 2017-18 by 8.5% and 6.3% (CAGR). However, at constant prices, this year’s allocation in MNREGA has declined from last year’s expenditures while food subsidy, which is marginally higher than last year, has declined from expenditures of 2015-16. Health and nutritional status heavily depend upon these allied sectors and their continued neglect is a concern.

Note: Umbrella child welfare and anganwadi services in secondary axis. Source: Union Budget documents.

Note: Umbrella child welfare and anganwadi services in secondary axis.
Source: Union Budget documents.

Lacking public health perspective

This year’s Budget thus continues with the policy of promoting high-end medical care services while ignoring primary care sector and other broader non-medical inputs of health. These sectors are crucial in improving the performance of health systems, which the NHP 2015 aims for. The long standing promise of ‘universal, free, comprehensive primary healthcare services’, which even the draft NHP 2015 reiterates, still goes unattended while the institutional and human resources priorities respond to the demands of a growing medical market.

Upgrading district hospitals into medical colleges might go a long way in creating additional 5,000 post graduate seats per year as highlighted by the finance minister’s Budget speech, but it still may not accomplish the objective of filling the shortage of specialist doctors in public institutions. Proliferation of a largely unregulated private health sector, with its profits unchecked in absence of a robust public sector, will still attract more doctors, particularly when public sector posts are becoming contractual.

While there is indeed a need to expand public hospitals, it cannot be made at the cost of the primary sector. The poor incur huge out-of-pocket expenditure not only for illnesses that require hospital services, but also due to the unavailability of free primary care. Some even fall sick in the first place due to poor nutrition, particularly children and pregnant women. The public secondary and tertiary care hospitals are clogged up with cases that are preventable at anganwadi centres or treatable at a primary level. A lopsided expansion of high-end hospitals and only some upgradation of existing district hospitals without paying heed to the problems of public health and primary care sector, and no real expansion of first-referral care at the CHCs will only perpetuate this problem. The tragedy is that due to such misallocation of resources, these paltry increases in allocation in public healthcare will not yield any visible benefit to a large section of the population.

Sourindra Mohan Ghosh is PhD scholar at the Centre for Economic Studies and Planning, Jawaharlal Nehru University, New Delhi and a consultant at the Council for Social Development. Imrana Qadeer is retired professor at the department of social medicine and community health, Jawaharlal Nehru University and distinguished professor at the Council for Social Development, New Delhi.

Note Ban May Exacerbate India’s Public Health Crisis

Private hospitals have not been allowed to use the defunct Rs 500 and Rs 1000 notes, potentially affecting 58% of Indians in rural areas and 68% in urban areas who opt for private healthcare.

Private hospitals have not been allowed to use the defunct Rs 500 and Rs 1000 notes, potentially affecting 58% of Indians in rural areas and 68% in urban areas who opt for private healthcare.

Mahavir Malhar, 52, from Jharkhand came to Mumbai for his wife Jharia's cancer treatment. Credit: IndiaSpend/Swagata Yadavar

Mahavir Malhar, 52, from Jharkhand came to Mumbai for his wife Jharia’s cancer treatment. Credit: IndiaSpend/Swagata Yadavar

A spate of deaths due to hospitals refusing to accept invalid currency notes has come to attention after Prime Minister Narendra Modi’s announcement invalidating 86% of India’s currency on November 8.

Unlike government-run hospitals, private hospitals have not been allowed to use defunct Rs 500 and Rs 1000 notes, potentially affecting 58% of Indians in rural areas who opt for private healthcare (68% in urban areas), according to National Sample Survey Office (NSSO) data.

In Noida, an infant died after union minister Mahesh Sharma’s Kailash Hospital reportedly asked for an advance of Rs 10,000 and then refused to take old currency notes.

An 18-month old baby died in Visakhapatnam as the parents didn’t have money to buy medicines, and a year-old infant in Mainpuri, Uttar Pradesh, died after reportedly being denied treatment by a local private doctor as his parents didn’t have money to pay for his treatment.

Despite multiple requests, finance minister Arun Jaitley said on November 17 that private hospitals would not accept old notes because that would encourage misuse of old currency.

Patients who had travelled away from their home states were particularly caught unaware by the move and faced a serious shortage of cash.

On a Mumbai footpath, a cancer patient and husband from Jharkhand struggle

IndiaSpend met 52-year-old Mahavir Malhar and his wife from Jharia, Jharkhand, staying on the footpath outside Mumbai’s Tata Memorial Hospital, a leading referral hospital for cancer patients nationwide. A labourer who earned Rs 200 every day before coming to Mumbai to address his wife’s ear cancer, Malhar had no usable cash.

“We do not have cash to buy meals or even tea,” said Malhar. Although treatment at Tata Memorial Hospital is free, and the hospital accepts old notes, staying in Mumbai is expensive for the couple. Since the note ban, their sons, also labourers, have not been able to send them money because of long lines at local banks.

“They are also daily wage earners and standing in a line for the whole day means loss of income,” said Malhar. The couple now depends on the free meals provided by the hospital and charitable trusts.

Indians spend eight times more in a private hospital than in a government institution

As we said, more than half of India’s population depends on private healthcare, despite the fact that private healthcare cost the poorest 20% of Indians more than 15 times their average monthly expenditure, according to this 2014 NSSO survey.

Other markers of India’s dependence on private healthcare:

  • Up to 86% of the rural population (717 million people) and 82% of the urban population (309 million people) are without health expenditure support, IndiaSpend reported in July 2015.
  • Indians spend eight times more in a private hospital than a government hospital, according to an analysis of National Health Accounts (NHA) 2013-14 data by The Hindu. The report estimated that households spent Rs 8,193 crore in government hospitals, an eighth of the Rs 62,628 crore spent in private hospitals.
  • As much as 69% of health expenditure in India is private (out-of-pocket) – the highest proportion in the world – according to NHA data. Out-of-pocket expenditure is the share of expenses that patients pay to the healthcare provider without third-party insurance or government-subsidised treatment.
  • Of the 930,000 doctors in the country, only 106,000 work for the government. This means there is one government doctor for every 11,528 people, according to the National Health Profile 2015 reportIndiaSpend reported in November.
  • About 81% sanctioned posts of specialist medical professionals in community health centres were lying vacant, according to this 2015 rural health statistics report.

Therefore, the government’s decision to not allow private hospitals to accept old notes will restrict access to healthcare for a significant section of Indians, Scroll reported on November 21.

Post demonetisation, the Maharashtra government’s toll-free 108 helpline – the 24×7 emergency ambulance services number – is also reporting complaints against private hospitals refusing to accept cheques. The Scroll report talked about angry callers unable to buy medicines or seek treatment due to private hospitals not accepting Rs 500/1000 notes.

Private hospitals report a fall in patients

Lack of cash is making patients prioritise their cash needs, and health issues tend to be pushed back on family priority lists, reported private practitioners from urban centres.

“There has a been a drop of 25-30% in patients coming to our private out-patient (OPD) department,” said Manish Motwani, a bariatric surgeon at Aastha Health Care, Mumbai. He attributed the drop to a fall in non-emergency cases.

“There was a 40% drop in my patients in the OPD the next day of demonetisation; now the drop is of 10-15%, but some of my other colleagues are seeing a drop of 50% in the number of hospitalisations,” said Pradeep Gadge, a Mumbai diabetologist. Many doctors said they were allowing patients known to them to pay later.

There has also been an increase in the number of patients in government hospitals, where treatment is largely free or at nominal charges. “We have seen an increase in the number of patients in our primary healthcare centre since the currency ban,” said Amol Bhusare, medical officer at Pallam, a small town in Maharashtra’s Marathwada region, east of Mumbai. Bhusare said two of his patients who had gone to a private diagnostic centre for a CT scan at the nearby Nanded city were turned back for bringing old notes.

Akhilesh Yadav, chief minister of Uttar Pradesh, requested Modi and Jaitley on November 17 to allow Rs 500 and Rs 1000 notes at private hospitals and medicine shops till November 30.

“As Rs 500 and Rs 1000 [notes] were banned in haste, those undergoing treatment at hospitals and nursing homes are facing a lot of problems,” said Yadav. “I, therefore, request you to intervene and allow private hospitals, nursing homes and medicine shops to accept these notes till at least November 30.”

A few hospitals have pleaded that they be allowed to accept older currency. Mumbai’s Bhatia Hospital wrote to the prime minister the day after his initial note-ban announcement. “We are one of the oldest charitable hospitals in Mumbai and requested [that] at least charitable hospitals be allowed to accept older notes,” said Rajeev Boudhankar, CEO of Bhatia Hospital. He said no patient has been turned away. They are accepting payments through other means, including cheques, although three cheques have bounced.

Devanik Saha is an MA Gender and Development student at Institute of Development Studies, University of Sussex. Swagata Yadavar is principal correspondent with IndiaSpend.

This article was originally published on IndiaSpend.

Compulsory Licenses Needed in India to Ensure Affordable Medicines

NSS data reveals that a majority of rural and urban populations did not get proper medical treatment because of the expense.

NSS data reveals that a majority of rural and urban populations don’t get proper medical treatment because of the expense.

Credit: Jamie/Flickr CC BY 2.0

Credit: Jamie/Flickr CC BY 2.0

The latest decennial National Sample Survey (NSS) report on morbidity and health, released recently by the Ministry of Statistics and Programme Implementation, provides important leads for why India should more proactively make medicines more affordable. This includes resorting to measures including compulsory licenses to reduce the cost of medicines. It shows that medicines account for much of people’s spending on health care. In outpatient care (non-hospitalisation) where more than four-fifth of reported cases of ailments got treated in urban and rural areas, expenditure on medicines (only allopathic medicines) account for 68% in rural areas and 64% in urban areas of total medical expenditure. This shows how critical medicines are to our healthcare system as compared to advanced countries, where cost of medicines in healthcare expenditure is much less significant.

What would people do when they are ill, if they do not have the capacity to pay for medicines? They will not get proper treatment and resort to alternatives such as home remedies whenever possible. Four percent of the sick in rural areas and 2.5% in urban areas took no care at all, analysis in Sundararaman and Muraleedharan’s  article on NSS data shows. Of those who resorted to alternatives such as self-medication, this NSS report shows that 57% in rural areas and 68% in urban areas did not turn to professional medical treatment due to financial constrains. This is very different from other factors such as ailment not considered serious or lack of healthcare facilities in the neighbourhood. If a large number of people are opting out of proper treatment due to financial reasons, the cost of medicines is the most significant contributing factor.

Cancer provides the best example of cost of medicines preventing people from getting treatment. There are a number of new patented cancer drugs whose prices are very high. Out of an estimated 1.1 million cancer patients in India, only 36% are receiving treatment, statistics presented by V. Shanta of the Adyar Cancer Institute show. The NSS report also shows that cancer involves the highest expenditure for treatment among all diseases. The medical expenditure for cancer was more than six times the average medical expenditure (for all diseases) in urban areas and more than double in rural areas.

Compulsory licenses

These observations assume greater significance in the light of the discussions in India on issuing compulsory licenses. The patent law in India allows granting of compulsory license to produce and sell cheaper versions of drugs under certain circumstances, including if drugs are priced so high that they are not affordable to patients. India has so far granted only one compulsory license. Applications by BDR Pharma on a cancer drug and Lee Pharma on a type II diabetes drug were rejected for various reasons.

The Pharmaceutical Research and Manufacturers of America and US-India Business Council, in their inputs to United States Trade Representative for the Special 301 Report 2016, submitted that India had privately assured US business that Indian patent office would adopt a stringent approach in granting compulsory licenses. The government of India refuted this allegation through a press release. The National Human Rights Commission of India, however, issued a press release in April this year expressing concerns on the media reports over the private assurance given by the government and the denial of the two applications for compulsory licenses, emphasising the responsibility of the government to provide affordable healthcare to its citizens.

Lee Pharma’s application was rejected in January this year as it was not able to satisfy the Patent Office of India that the reasonable requirements of the public were not met by the patented medicine. The Patent Office wanted Lee Pharma to provide data, among other things, on the number of people affected by Type II Diabetes, alternate drugs available and their market share to see if the requirement of the public was actually met with. But the fact is that this data is not available in the public domain. The market share data which the National Pharmaceutical Pricing Authority relies on for regulating drug prices is not shared with the public. It is not fair of the Patent Office to insist on data which is not publicly available, thereby denying more patients the opportunity to access healthcare services. Rather, evidence coming out of this NSS report should be used by the stakeholders to understand the significance of cost of medicines in India’s healthcare system.

Reji K. Joseph is Associate Professor at Institute for Studies in Industrial Development (ISID), New Delhi.